Stay updated on Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record adds a U.S. NIH grant/contract funding line, and the page footer updates to Revision: v3.6.6, indicating a minor version update.
    Difference
    0.1%
    Check dated 2026-08-29T23:43:08.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page’s revision is updated to v3.6.5 from v3.6.4, indicating a minor internal update to the page.
    Difference
    0.0%
    Check dated 2026-08-08T20:00:24.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a new deployment of the site. This update does not reflect a substantive change to the study details or content on the page.
    Difference
    0.0%
    Check dated 2026-07-25T12:32:28.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a new release of the page content.
    Difference
    0.0%
    Check dated 2026-07-03T23:53:15.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.0 to v3.6.2, indicating a newer version of the page template. This update does not alter any study content, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-06-26T19:46:42.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also applies a formatting change to the Intervention/Treatment label and adds a Revision: v3.6.0 note, replacing the prior Intervention / Treatment label and Revision: v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T12:17:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.